Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders
None
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2012
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/27869 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Role of 123I-Metaiodobenzylguanidine Myocardial Scintigraphy in Parkinsonian Disorders
- Risk Stratification of Sudden Cardiac Death by Evaluating Myocardial Sympathetic Nerve Activity Using Iodine-123 Metaiodobenzylguanidine Scintigraphy in Patients with Chronic Heart Failure and Dilated Cardiomyopathy
- Role of Fatty Acid Imaging with 123I- β-methyl-p-123I- Iodophenyl-Pentadecanoic Acid (123I-BMIPP) in Ischemic Heart Diseases
- Dystonia in Parkinsonian Syndromes
- Parkinsonian disorders in clinical practice /
- Relevance of Aerodynamic Evaluation in Parkinsonian Dysarthria
- Filterable Forms of Nocardia: An Infectious Focus in the Parkinsonian Midbrains